Hoth Therapeutics, Inc.HOTH

Market cap

$14.19M

P/E ratio

	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	282,621	2	3	9	6	9	7
Prepaid expenses and other current assets	-	-	-	-	-	135,361	605,948
Total Current Assets	501,648	3	5	11	7	9	8
Total right-of-use asset, net	-	-	-	-	-	55,165	31,075
Investment in joint ventures at fair value	-	-	-	-	33,000	37,400	36,819
Total Non-Current Assets	2,268	201,043	460,000	410,000	33,000	92,565	67,894
Total Assets	503,916	3	5	11	7	10	8
Accounts payable	142,280	403,885	129,469	360,964	694,989	35,592	412,071
Accrued expenses	206,671	36,236	128,180	426,823	667,742	614,226	390,760
Operating lease liability, current portion	-	-	-	-	-	28,839	28,366
Total Current Liabilities	348,951	440,121	312,149	867,787	1	678,657	831,197
Operating lease liability, less current portion	-	-	-	-	-	26,326	2,709
Total Long-Term Liabilities	-	-	285,000	235,000	250,000	26,326	2,709
Total Liabilities	348,951	440,121	597,149	1	2	704,983	833,906
Preferred stock, value	310	-	-	-	-	-	-
Common stock, $0.0001 par value; 50,000,000 shares authorized; 8,042,747 and 4,348,129 shares issued and outstanding as of December 31, 2024 and 2023, respectively	507	1,012	1,343	2,398	130	435	804
Additional paid-in capital	5	15	24	44	50	62	67
Accumulated deficit	-4,511,006	-12,215,642	-19,413,458	-33,727,163	-45,099,116	-52,944,506	-60,410,041
Accumulated other comprehensive income	-	-	-15,351	17,586	22,006	27,260	9,063
Total Stockholders’ Equity	154,965	2	5	10	5	9	7
Total Liabilities and Stockholders’ Equity	503,916	3	5	11	7	10	8